As I mentioned earlier, our testing and contact tracing teams are now focusing on targeting those who are most vulnerable to harm in our society. People who are at high risk of becoming severely ill due to COVID-19 are eligible for treatment with antiviral or antibody therapies. If those people who are eligible for treatment test positive for COVID-19 and report their lateral flow test result, they will usually be contacted by text or telephone call by the national antiviral service within 48 hours, and they will be offered treatment. We are also using multiplex PCR tests for our most vulnerable, including care home residents and others, and these tests test for other respiratory viruses alongside COVID-19 and can support treatment and manage outbreaks.

This winter, we will be strengthening our surveillance system to identify any deterioration in the situation, such as from new, harmful variants of concern and other respiratory viruses. A major purpose of the surveillance system will be to determine whether Wales has moved from a COVID-stable to a COVID-urgent state, either through the epidemiological—it's difficult to say that word, isn't it? Epidemiological indicators. Was that okay? Or from genomic surveillance indicating the presence of a more severe variant.

During this autumn and winter, we're focusing on enhancing and establishing more robust community and hospital surveillance systems that will further enhance the information we receive from the Office for National Statistics survey, as well as the wastewater analysis and other intelligence. The continual assessment of these data sources contributes to our ongoing surveillance.

Despite all of our plans around vaccination, testing, treatment and surveillance, we know that COVID-19 has placed sustained pressure on the NHS in Wales, both from people being treated directly for COVID-19 and people testing positive but being treated for other reasons, along with staff absence due to infection, the requirement to self-isolate or family illness. Given the exceptional nature or scale of some of the potential risks faced this winter, particularly in relation to COVID and other respiratory viruses, and the system's capacity and capability to respond to demand, additional winter operational planning guidance is being developed for NHS organisations. These NHS organisations will need to ensure that robust and resilient plans are in place, including joint action through regional partnership boards.

We are also acutely aware of the significant challenges faced by our communities this winter as a result of the cost-of-living crisis. We will be developing practical advice and guidance to support individuals and communities to keep well this winter. For example, we know that maintaining key protective behaviours—and we have all become familiar with them by now—can have significant benefits that go beyond COVID-19. Continuing with these behaviours will help to reduce impact of future waves of infection, and will also reduce the impacts from other respiratory infections. However, in the context of the cost-of-living crisis and fuel poverty, we recognise that these will be more challenging this winter and when we have cold weather. So, the key message to protect yourself, your family and others is to ensure that you are vaccinated and stay up to date with any COVID-19 booster vaccinations. Thank you, Llywydd.